Ranking Year:
# | Company Name | Region | Tech Topics | Total |
|---|
1 |  STARTUP | Health care | Patent: 3 | |
2 |  STARTUP | Patent: 3 | ||
3 | Patent: 2 | |||
4 | Patent: 2 | |||
5 |  | Patent: 2 |
Top 5 New Entrants companies in Hyperlipidemia
by Most Patent Filing In 3 Years in the South Korea in 2022
The Hyperlipidemia top 5 is Discovery PatSnap’ annual ranking of the top 5 Most Patent Filing In 3 Years Hyperlipidemia New Entrants in the South Korea. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Hyperlipidemia is abnormally elevated levels of any or all lipids or lipoproteins in the blood. It is the most common form of dyslipidemia (which includes any abnormal lipid levels). Lipids (water-insoluble molecules) are transported in a protein capsule. The size of that capsule, or lipoprotein, determines its density. The lipoprotein density and type of apolipoproteins it contains determines the fate of the particle and its influence on metabolism.
Page generation time:
Dec 14 2025